Search filters
Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Featured study
Neurobiology of Caregiving in New Mothers (Children between 0-3 years old)

Neurobiology of Caregiving in New Mothers (Children between 0-3 years old)

1 years - 42 years
Female
This study is to learn more about social processes on a behavioral and brain level in new mothers. If you are eligible, there are three in person visits, one consisting of an fMRI scan. MRI uses magnetic fields to take pictures of the brain. MRI does not use X-rays and …
Learn More
Featured study
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease (NefIgArd)

A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease (NefIgArd)

1 years - 100 years
All genders
Phase 3
The research study is being conducted to see how well the investigational drug, Nefecon, works for the treatment of your kidney disease and more specific for patients with "primary immunoglobulin A nephropathy," called IgAN.
Learn More
Featured study
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS-IgAN)

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS-IgAN)

18 years - 80 years
All genders
Phase 3
This study will use a new investigational study drug called OMS721 in people with Immunoglobulin A (IgA) Nephropathy. This kidney disease produces abnormal amounts of a protein called IgA in the kidney that damage the filtering units or glomeruli. Glomeruli are tiny filtering units in the kidney that remove excess …
Learn More
Featured study
The Penn Medicine BioBank

The Penn Medicine BioBank

18 years - 100 years
All genders
Observational
The purpose of this study is to investigate the collection and storage of biological samples for conditions such as COVID-19, cancer, diabetes, and heart disease.This study evaluates how biological samples and health information can be used in research to enhance understanding and treatment of various conditions.Who can participate: Adults over …
Learn More
Featured study
Digital Data and Heart Health | Using Digital Data to Predict Heart Disease

Digital Data and Heart Health | Using Digital Data to Predict Heart Disease

30 years - 74 years
All genders
Observational
What is the purpose of this study?   This research study is exploring about how digital data (ie. social media, online searches, and step tracking data) are associated with Coronary Heart Disease (CHD) and related risk factors in order to develop a more precise CHD risk predictor tool.   We …
Learn More
Featured study
CARE2-IS: CARegivers of children with Eczema: a health CARE Interview Study

CARE2-IS: CARegivers of children with Eczema: a health CARE Interview Study

18 years - 100 years
All genders
Eczema, or atopic dermatitis, is a common skin disease among children. Use of and access to health care for eczema is variable among children across different racial and ethnic groups. The purpose of this study is to understand the caregiver’s experience with caring for their child with eczema, barriers that …
Learn More
Featured study
A Translational and Neurocomputational Evaluation of a D1R Partial Agonist for Schizophrenia

A Translational and Neurocomputational Evaluation of a D1R Partial Agonist for Schizophrenia

18 years - 45 years
All genders
Phase 1
The purpose of this research is to test an experimental drug CVL-562 as a possible treatment for early-course schizophrenia, schizoaffective disorder or related psychotic disorder.This study will test whether CVL-562 can help thinking and memory in people with schizophrenia.
Learn More
Featured study
Supplement Screening for Breast Cancer with Abbreviated MRI for Black Women with Increased Breast Density

Supplement Screening for Breast Cancer with Abbreviated MRI for Black Women with Increased Breast Density

40 years - 75 years
Female
It is well known that black women develop breast cancers which present not only at an earlier age when breasts are denser, but also the cancers tend to be more aggressive subtypes than those found in Caucasian women of a similar age. In addition, the population-based breast cancer mortality for …
Check Eligibility
Featured study
CLadribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous System BiomarKers in Multiple Sclerosis

CLadribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous System BiomarKers in Multiple Sclerosis

18 years - 65 years
All genders
The purpose of this study is to better understand the mechanism of action of cladribine tablets. The study will generate hypotheses regarding the impact of cladribine tablet activity in the CNS by assessing the cerebrospinal fluid (CSF) levels of lymphocyte subsets, neuronal injury markers, & soluble immunological markers in study …
Learn More
Featured study
Drivingly: Promoting Driver Safety in Adolescence

Drivingly: Promoting Driver Safety in Adolescence

15 years - 100 years
All genders
Researchers at the University of Pennsylvania are working on a study aimed at reducing teens risk for motor vehicle crashes (MVCs). We are looking for parents and teens to participate in a research study designed to identify effective programs that will help us better understand how to promote safe teen …
Learn More
41 - 50 of 1243